ERLOTINIB (ERLOTINIB HYDROCHLORIDE) — all Canadian products
14 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ERLOTINIB (ERLOTINIB HYDROCHLORIDE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02461889 | APO-ERLOTINIB | APOTEX INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Marketed | |
| 02461870 | APO-ERLOTINIB | APOTEX INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Marketed | |
| 02461862 | APO-ERLOTINIB | APOTEX INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Marketed | |
| 02454394 | PMS-ERLOTINIB | PHARMASCIENCE INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Marketed | |
| 02377691 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Marketed | |
| 02377705 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Marketed | |
| 02377713 | TEVA-ERLOTINIB | TEVA CANADA LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Marketed | |
| 02483939 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Dormant | |
| 02483912 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Dormant | |
| 02483920 | NAT-ERLOTINIB | NATCO PHARMA (CANADA) INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Dormant | |
| 02454386 | PMS-ERLOTINIB | PHARMASCIENCE INC | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Dormant | |
| 02269015 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 100 MG | Cancelled Post Market | |
| 02269007 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 25 MG | Cancelled Post Market | |
| 02269023 | TARCEVA | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | ERLOTINIB (ERLOTINIB HYDROCHLORIDE) 150 MG | Cancelled Post Market |
Browse other molecules: